ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $286,000 | -34.3% | 4,309 | -38.2% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | -55.8% | 6,967 | -41.4% | 0.00% | -50.0% |
| Q2 2021 | $984,000 | +42.4% | 11,882 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $691,000 | -24.8% | 10,425 | -13.0% | 0.00% | 0.0% |
| Q4 2020 | $919,000 | +184.5% | 11,982 | +59.8% | 0.00% | +100.0% |
| Q3 2020 | $323,000 | -50.5% | 7,499 | -50.4% | 0.00% | -50.0% |
| Q2 2020 | $653,000 | -66.6% | 15,127 | -77.7% | 0.00% | -81.8% |
| Q1 2020 | $1,954,000 | -78.6% | 67,923 | -52.9% | 0.01% | -76.6% |
| Q4 2019 | $9,138,000 | +86.0% | 144,067 | -17.4% | 0.05% | +56.7% |
| Q3 2019 | $4,914,000 | – | 174,380 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |